Zobrazeno 1 - 10 of 416 pro vyhledávání: '"Lenzi, G L"'
1
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial
Autor: Laroni A., Brogi D., Morra V. B., Guidi L., Pozzilli C., Comi G., Lugaresi A., Turrini R., Raimondi D., Uccelli A., Mancardi G. L., Amato M. P., Appendino L., Ardito B., Avolio C., Bandini F., Batocchi A. P., Bellantonio P., Benedetti M. D., Bergamaschi R., Bortolon F., Bosco A., Buccafusca M., Cargnelutti D., Cavalla P., Cavallo R., Centonze D., Coniglio M. G., Costantino G., Cottone S., Danni M. C., De Robertis F., Deotto L., Dotta M., Di Battista G., Filippi M. M., Florio C., Francia A., Galgani S., Gallo P., Ghezzi A., Giometto B., Giuliani G., Grimaldi L. M. E., Guidotti M., Iudice A., Lenzi G. L., Lorusso L., Lus G., Maimone D., Malentacchi G. M., Mantegazza R. E., Massacesi L., Melato M., Millefiorini E., Montanari E., Patti F., Perrone P. S. M., Protti A., Provera P., Quattrone A., Rasi F., Rosati G., Rovaris M., Sacca F., Salemi G., Sarchielli P., Scarpini E. A., Schoenhuber R., Serrati C., Sinisi L., Sola P., Spitaleri D. L. A., Tedeschi G., Tezzon F., Tinebra Asti M. C., Tola M. R., Totaro R., Trojano M., Ulivelli M., Vecchio M. M., Zimatore G. B.
Publikováno v: BMC Neurology
Publons
BACKGROUND: In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ce21ba9dc53742ec8deb68df909976
http://hdl.handle.net/11585/546663
Zobrazit plný text záznamu
2
Cerebral Venous Thrombosis Revealing Primary Sjögren Syndrome: Report of 2 Cases
Autor: Mercurio, A., Altieri, M., Saraceni, V. M., Paolucci, T., Lenzi, G. L.
Publikováno v: Case Reports in Medicine.
Sjögren syndrome (SS) is an autoimmune disease of the exocrine glands, characterized by focal lymphocytic infiltration and destruction of these glands. Neurologic complications are quite common, mainly involving the peripheral nervous system (PNS).
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=hindawi_publ::7267e67ec8d7eb2c0a03336cb698e645
Zobrazit plný text záznamu
3
Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial
Autor: Lenzi, G. L., Grigoletto, F, Gent, M, Roberts, R. S., Walker, M. D., Easton, J. D., Carolei, Antonio, Dorsey, F. C., Rocca, W. A., Bruno, R, Patarnello, F, Fieschi, C, AND THE EARLY STROKE TRIAL GROUP
Publikováno v: Stroke. 25:1552-1558
The Early Stroke Trial (EST) is a randomized, double-blind, placebo-controlled trial to assess the effect of monosialoganglioside GM-1 in improving recovery in patients who experienced an ischemic supratentorial stroke. Sixteen clinical centers recru
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a11d2bf7366d2dc6217727d0e894c1a4
https://doi.org/10.1161/01.str.25.8.1552
Zobrazit plný text záznamu
6
Stroke beyond the first hours: The role of monitoring
Autor: Tombari, D., Ricciardi, Maria Chiara, Bonaffini, N., Pasquini, M., Cecconi, M., DI PIERO, Vittorio, Lenzi, G. L.
It is now recognized that a specialized multidisciplinary team, focusing on the care of stroke patients, leads to lower mortality and better outcomes. The positive effect of stroke units in regard to the outcome of stroke patients seems to be related
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4ff733382b0b70efae8e8ff4d25e2c
http://hdl.handle.net/11573/363452
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje